74 related articles for article (PubMed ID: 12679613)
1. Involvement of IL-18 and soluble fas in patients with postoperative hepatic failure.
Nakae H; Zheng YJ; Wada H; Tajimi K; Endo S
Eur Surg Res; 2003; 35(2):61-6. PubMed ID: 12679613
[TBL] [Abstract][Full Text] [Related]
2. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
Nakae H; Narita K; Endo S
J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
[TBL] [Abstract][Full Text] [Related]
3. Serum apoptosis markers in acute liver failure: a pilot study.
Rutherford AE; Hynan LS; Borges CB; Forcione DG; Blackard JT; Lin W; Gorman AR; Shaikh OS; Reuben A; Harrison E; Reddy KR; Le WM; Chung RT;
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1477-83. PubMed ID: 17967565
[TBL] [Abstract][Full Text] [Related]
4. Soluble Fas and soluble Fas L levels in patients with acute pancreatitis.
Endo S; Inoue Y; Fujino Y; Yamada Y; Sato N; Wakabayashi G; Sakamoto T; Ishikura H; Tanaka T; Inada K; Sato S
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):179-86. PubMed ID: 11913710
[TBL] [Abstract][Full Text] [Related]
5. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
[TBL] [Abstract][Full Text] [Related]
6. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
[TBL] [Abstract][Full Text] [Related]
7. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome.
Doughty L; Clark RS; Kaplan SS; Sasser H; Carcillo J
Pediatr Res; 2002 Dec; 52(6):922-7. PubMed ID: 12438671
[TBL] [Abstract][Full Text] [Related]
8. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
9. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
Takabatake N; Nakamura H; Inoue S; Terashita K; Yuki H; Kato S; Yasumura S; Tomoike H
Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
[TBL] [Abstract][Full Text] [Related]
11. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose.
Tagami A; Ohnishi H; Hughes RD
Hepatogastroenterology; 2003; 50(51):742-5. PubMed ID: 12828076
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure.
Kuhla A; Eipel C; Siebert N; Abshagen K; Menger MD; Vollmar B
Apoptosis; 2008 Dec; 13(12):1427-38. PubMed ID: 18946736
[TBL] [Abstract][Full Text] [Related]
13. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis.
Tokushige K; Yamaguchi N; Ikeda I; Hashimoto E; Yamauchi K; Hayashi N
Am J Gastroenterol; 2000 Aug; 95(8):2040-6. PubMed ID: 10950055
[TBL] [Abstract][Full Text] [Related]
14. Soluble Fas and soluble FasL in multiple organ dysfunction syndrome complicating diffuse peritonitis.
Kitamura M; Endo S; Sato N; Yaegashi Y; Suxzuki Y; Kojika N; Wakabayashi G
Res Commun Mol Pathol Pharmacol; 2004; 115-116():235-42. PubMed ID: 17564320
[TBL] [Abstract][Full Text] [Related]
15. Acute liver failure: mechanisms of hepatocyte injury and regeneration.
Rutherford A; Chung RT
Semin Liver Dis; 2008 May; 28(2):167-74. PubMed ID: 18452116
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB.
Nagaki M; Naiki T; Brenner DA; Osawa Y; Imose M; Hayashi H; Banno Y; Nakashima S; Moriwaki H
Hepatology; 2000 Dec; 32(6):1272-9. PubMed ID: 11093734
[TBL] [Abstract][Full Text] [Related]
17. Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib.
Nagai H; Kanekawa T; Kobayashi K; Mukozu T; Matsui D; Matsui T; Kanayama M; Wakui N; Momiyama K; Shinohara M; Ishii K; Igarashi Y; Sumino Y
Cancer Chemother Pharmacol; 2014 Feb; 73(2):223-9. PubMed ID: 24220937
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic mechanisms in fulminant hepatic failure: potential therapeutic target.
Singhal S; Jain S; Kohaar I; Singla M; Gondal R; Kar P
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):282-5. PubMed ID: 19077906
[TBL] [Abstract][Full Text] [Related]
20. Changes of cytokines in cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
Cancer Chemother Pharmacol; 2008 Jul; 62(2):271-6. PubMed ID: 17899083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
